Literature DB >> 6386876

Comparative assessment of in vitro inactivation of gentamicin in the presence of carbenicillin by three different gentamicin assay methods.

S C Ebert, J H Jorgensen, D J Drutz, W A Clementi.   

Abstract

Inactivation of gentamicin (G) is known to occur secondarily to the formation of complexes with certain beta-lactam antibiotics. However, aminoglycosides in the presence of aminoglycoside-beta-lactam complexes may not be recognized uniformly by all assay methods. We tested this hypothesis by using mixtures of G plus carbenicillin (C), with and without the addition of penicillinase, in pooled sera under several in vitro conditions: at 25 and 35 degrees C and at low and high C concentrations. Samples were assayed for G with the EMIT and TDx systems, and a microbiological assay was performed with a strain of Klebsiella pneumoniae resistant to C. In the presence of C (500 micrograms/ml) at 35 degrees C, the initial G concentration of 5 micrograms/ml decreased markedly over 48 h as assessed by all three assay methods. However, significantly greater degradation was noted when samples were measured by microbiological assay and TDx than by EMIT. Differences between assays were less marked when mixtures were studied at a lower temperature and with a lower G to C ratio (5 micrograms of G plus 100 micrograms of C per ml). The addition of penicillinase to the antibiotic mixtures prevented the degradation of G over time when measured by all three assay systems. We concluded (i) that EMIT measures higher serum concentrations of G than do TDx or microbiological assays when complexes of G and C are present and (ii) that the addition of penicillinase to serum samples containing C and G would be effective in preventing G degradation during prolonged (greater than 24-h) periods between the time of sampling and assay.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6386876      PMCID: PMC271415          DOI: 10.1128/jcm.20.4.701-705.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Interactions between aminoglycoside antibiotics and carbenicillin or ticarillin.

Authors:  H A Holt; J M Broughall; M McCarthy; D S Reeves
Journal:  Infection       Date:  1976       Impact factor: 3.553

2.  Rapid gentamicin bioassay using a multiple-antibiotic-resistant strain of Klebsiella pneumoniae.

Authors:  M E Lund; D J Blazevic; J M Matsen
Journal:  Antimicrob Agents Chemother       Date:  1973-11       Impact factor: 5.191

3.  Clinical and laboratory evidence for inactivation of gentamicin by carbenicillin.

Authors:  J E McLaughlin; D S Reeves
Journal:  Lancet       Date:  1971-02-06       Impact factor: 79.321

4.  Laboratory and clinical conditions for gentamicin inactivation by carbenicillin.

Authors:  L J Riff; G G Jackson
Journal:  Arch Intern Med       Date:  1972-12

5.  Radioimmunoassay, acetylating radio-enzymatic assay, and microbioassay of gentamicin: a comparative study.

Authors:  P Stevens; L S Young; W L Hewitt
Journal:  J Lab Clin Med       Date:  1975-08

6.  Carbenicillin inactivation of aminoglycosides in patients with severe renal failure.

Authors:  R Weibert; W Keane; F Shapiro
Journal:  Trans Am Soc Artif Intern Organs       Date:  1976

7.  In-vitro inactivation of aminoglycoside antibiotics by piperacillin and carbenicillin.

Authors:  D C Hale; R Jenkins; J M Matsen
Journal:  Am J Clin Pathol       Date:  1980-09       Impact factor: 2.493

8.  Animal model distinguishing in vitro from in vivo carbenicillin-aminoglycoside interactions.

Authors:  J A Pieper; R A Vidal; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

9.  Gentamicin:adenine mononucleotide transferase: partial purification, characterization, and use in the clinical quantitation of gentamicin.

Authors:  A L Smith; D H Smith
Journal:  J Infect Dis       Date:  1974-04       Impact factor: 5.226

10.  Effect of time and concentration upon interaction between gentamicin, tobramycin, Netilmicin, or amikacin and carbenicillin or ticarcillin.

Authors:  L K Pickering; P Gearhart
Journal:  Antimicrob Agents Chemother       Date:  1979-04       Impact factor: 5.191

View more
  7 in total

1.  Role of sodium in protection by extended-spectrum penicillins against tobramycin-induced nephrotoxicity.

Authors:  R Sabra; R A Branch
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

2.  Attenuation of experimental tobramycin nephrotoxicity by ticarcillin.

Authors:  J English; D N Gilbert; S Kohlhepp; P W Kohnen; G Mayor; D C Houghton; W M Bennett
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191

3.  Ceftriaxone protects against tobramycin nephrotoxicity.

Authors:  D Beauchamp; G Thériault; L Grenier; P Gourde; S Perron; Y Bergeron; L Fontaine; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

4.  Comparative inactivation of isepamicin, amikacin, and gentamicin by nine beta-lactams and two beta-lactamase inhibitors, cilastatin and heparin.

Authors:  J N Walterspiel; S Feldman; R Van; W R Ravis
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

5.  Role of sodium in the protective effect of ticarcillin on gentamicin nephrotoxicity in rats.

Authors:  A Ohnishi; T D Bryant; K R Branch; R Sabra; R A Branch
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

6.  In vitro inactivation of aminoglycosides by apalcillin.

Authors:  D N Wright; D C Hale; B Saxon; J M Matsen
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

7.  An in vivo assessment of the tobramycin/ticarcillin interaction in cystic fibrosis patients.

Authors:  G W Roberts; R L Nation; A O Jarvinen; A J Martin
Journal:  Br J Clin Pharmacol       Date:  1993-10       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.